Clinical Trials Logo

Filter by:
NCT ID: NCT04402307 Completed - Dysphagia Clinical Trials

Effect of Training of Patients With Dysphagia

Start date: March 25, 2019
Phase: N/A
Study type: Interventional

Effect of training of patients with dysphagia

NCT ID: NCT04401579 Completed - COVID-19 Clinical Trials

Adaptive COVID-19 Treatment Trial 2 (ACTT-2)

Start date: May 8, 2020
Phase: Phase 3
Study type: Interventional

ACTT-2 will evaluate the combination of baricitinib and remdesivir compared to remdesivir alone. Subjects will be assessed daily while hospitalized. If the subjects are discharged from the hospital, they will have a study visit at Days 15, 22, and 29. For discharged subjects, it is preferred that the Day 15 and 29 visits are in person to obtain safety laboratory tests and oropharyngeal (OP) swab and blood (serum only) samples for secondary research as well as clinical outcome data. However, infection control or other restrictions may limit the ability of the subject to return to the clinic. In this case, these visits may be conducted by phone, and only clinical data will be obtained. The Day 22 visit does not have laboratory tests or collection of samples and is conducted by phone. The primary outcome is time to recovery by Day 29.

NCT ID: NCT04401514 Completed - Delirium Clinical Trials

Does Rocking Charis Calm Delirious Patients in the Intensive Care Unit

RocingICU
Start date: June 1, 2020
Phase: N/A
Study type: Interventional

Background: Delirium among patients admitted to an ICU is a common condition associated with increased morbidity and mortality. To this point no evidence-based prevention or treatment exist for delirium. Non-pharmacological interventions such as early mobilization and systematic bundle of care have been suggested to decrease the number of days of delirium. So far there exist no studies exploring if delirious patients benefit or not when mobilized to a rocking chair with music therapy. Objectives: To assess if rocking chair therapy can decrease the burden of delirium in adult, critical ill patients admitted to an ICU. Design: A clinical initiated multicenter randomized non-blinded trial, of delirious patients mobilized to a rocking chair versus no rocking chair. Inclusion and exclusion criteria: Inclusion criteria: Adult intensive care patients (18 years and above) diagnosed with delirium with a validated screening tool. Exclusion criteria: if the patient is evaluated not to be mobilized to a rocking chair and expressing discomfort and do not wish to be mobilized, a patient with critical illness neuropati, patients with lever coma, patient in ECM treatment, patients that are mentally permanently incompetent, not receiving active life support if needed, weight more that 130 kg, if informed consent cannot be obtained, if the patient is admitted because of suicide attempt and is the patient have delirium tremens. Intervention: The experimental intervention is a 20 min. long rocking chair with music therapy. Control intervention is also transferred to the rocking chair, but the therapy program will not be turned on. Standardized pharmacological and non-pharmacological interventions for delirium will continue for both groups. Delirium and consciousness will be evaluated twice a day. Outcomes: Primary outcome: number of days alive without coma and delirium in the ICU. Secondary outcome: Number of days admitted to the ICU and number of patients with at least one difference in RASS score before end after the experimental intervention. Trial size: A power calculation have estimated that a total number of 76 patients with delirium should be included in each study group. Time schedule: We estimate that the inclusion period and follow up will as long as 1 year from the time the first patient is randomized. Amendment's protocol Agreed by the project group August 22nd 2022, we will do an additional 90-day follow-up of all-cause mortality. This was agreed before the project group or statistician had access to the randomisation key and intervention data, and before any statistical analysis was started.

NCT ID: NCT04401306 Completed - Surgery Clinical Trials

Remote Training in Laparoscopy

Start date: March 1, 2019
Phase: N/A
Study type: Interventional

The study is a prospective, randomized comparative study using a mixed methods design. The primary objective is to compare the effect of self-regulated simulation training (SRST) to instructor-regulated simulation training (IRST) in basic laparoscopic skills. The study population is first-year trainees in the specialties General Surgery, Urology and Obstetrics and Gynaecology within the postgraduate training region of northern Denmark. 46 first-year trainees will be randomized into two groups, one receiving SRST and one receiving IRST in basic laparoscopic skills.

NCT ID: NCT04401163 Completed - Covid19 Clinical Trials

Long-term Pulmonary Outcomes After Infection With Sars-CoV-2

Start date: June 18, 2020
Phase:
Study type: Observational [Patient Registry]

The objective of this study is to assess the long-term outcomes after hospital admission with Covid-19 with respect to pulmonary function, physical capacity, imaging, quality of life and socioeconomic outcomes.

NCT ID: NCT04400318 Completed - Asthma Clinical Trials

The Effect of Dupilumab on Lung Inflammation and Related Changes in Airway Volumes Detectable by Functional Respiratory Imaging in Patients With Moderate-severe Asthma

VESTIGE
Start date: June 22, 2020
Phase: Phase 4
Study type: Interventional

Primary Objective: • To assess the effect of dupilumab on lung inflammation and related changes in airway volumes detectable by functional respiratory imaging Secondary Objective: - To evaluate the effect of dupilumab at Week 24 on bronchodynamics, hyperinflation, airway resistance, airway wall thickness, ventilation defects and mucus plugging derived from high-resolution computed tomography (HRCT) scans, patient-reported outcomes, FeNO and spirometry. - To evaluate safety of dupilumab

NCT ID: NCT04399928 Completed - Clinical trials for Degenerative Joint Disease

EU Safety and Efficacy Study Regarding the R3 Acetabular Hip System

Start date: May 18, 2009
Phase:
Study type: Observational

The objective of this study is to determine the long-term safety and effectiveness from the R3 Acetabular Hip System. The study hypothesis is that implant survivorship of the R3 cup is at least 97% at 3 years, 95% at 5 years, 93% at 7 years, and 90% at 10 years follow-up.

NCT ID: NCT04399772 Completed - Clinical trials for Chronic Low-back Pain

COgNitive FuncTional Therapy+ for Chronic Low Back paIn

CONFeTTI
Start date: September 27, 2020
Phase: N/A
Study type: Interventional

This study is a patient-blinded 2-arm randomized controlled trial (RCT) assessing the effectiveness (in the short and long term) as well as total healthcare costs of a CFT+ (a combined physiotherapist/psychologist intervention) pathway compared with interdisciplinary pain management pathway (usual care) for patients with chronic low back pain referred to interdisciplinary pain treatment. The primary aim of this pragmatic randomized controlled trial (RCT) is to investigate if a physiotherapy-led CFT pathway that includes psychologist support (CFT+) with the option of additional usual care (if needed) is superior to the currently recommended interdisciplinary pain management pathway (usual care) in reducing disability at 12 months in patients with severe cLBP. In addition, an economic evaluation will investigate total health care costs of the two pathways at 12 months. In addition the study will explore changes in pain intensity, quality of life, thoughts and beliefs about back pain, and analgesic consumption in patients randomized to the CFT+ pathway compared with patients randomized to the interdisciplinary pain management pathway.

NCT ID: NCT04398797 Completed - Clinical trials for Avoid Acute Hospitalizations

Prevention of AcuTe admIssioN Algorithm (PATINA)

Start date: June 1, 2020
Phase: N/A
Study type: Interventional

Utilization of public health care mirrors the older individual's overall health, and increased need for health care may precede more clear symptoms of acute disease. In a previous retrospective study, we found a significant increase in municipal home care service (minutes/week) in a 12-month period prior to acute hospitalization. This PhD-study aims at examining the effect of a software algorithm monitoring older citizens utilization of municipal home care. When home care increases the community nurse is notified and special attention is paid to the individual's current health situation. Pro-active health care initiatives may be launched in collaboration with the primary care physician. The intervention is the algorithm.

NCT ID: NCT04395664 Completed - COVID-19 Clinical Trials

Arrhythmias in Patients With COVID-19

ACOVID
Start date: April 16, 2020
Phase:
Study type: Observational

The study is a prospective clinical cohort study of consecutive patients hospitalized at all hospitals of greater Copenhagen with a laboratory confirmed diagnosis of COVID-19. The investigators aim to examine if continuous ECG monitoring can be used to understand the contribution of COVID-19 infection in the acute phase to the development of cardiac arrhythmias, especially focusing on cardiovascular outcomes. In all patients included, the investigators aim to examine if continuous ECG monitoring - alone and in combination with biomarkers - can be used to detect early signs of cardiac complications and predict long-term risk of cardiovascular morbidity and mortality following COVID-19 infection.